the weight loss pen tirzepatide GLP-1 medication may be most effective for Tirzepatide Dosing: Diabetes vs Weight

Research examining BPC-157 in alkali burn models produced encouraging results

Even though these results are intriguing, they are still preliminary, and more translational study is necessary before firm conclusions can be drawn

Injectable forms have a defensible role under medical supervision for specific indications

Figure from Rossing et al NDT 2023 Primary Outcome This was a composite of time of first occurrence of: Onset of kidney failure (persistent eGFR 28 days or initiation of long-term KRT, kidney transplantation) Persistent 50% reduction in eGFR from baseline Death from kidney or CV causes Secondary Outcomes Confirmatory secondary outcomes were analyzed hierarchically

While dozens of states have legalized it for medical use, the Food and Drug Administration (FDA) still treats it like a substance thats prone to cause drug abuse